The Food and Drug Administration has set maximum levels for lead in baby foods like jarred fruits and vegetables, yogurts and ...
Montenegro has approved the extradition of a South Korean mogul known as “the cryptocurrency king” to the United States, the Balkan country's Justice Ministry said Friday. Minister Bojan ...
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb’s BMY-N blockbuster cancer drug, Opdivo. Opdivo is part of a class of ...
Cosmetic companies would have to take extra steps to ensure that any products containing talc are free of asbestos under a federal rule proposed Thursday. The proposal from the ...
removed from distribution due to the "potential for pieces of metal" inside the products, according to multiple FDA recall reports. Metals can have an array of harmful effects on the body.
Hikma said on Monday it was “pleased to have FDA approval to launch this important medicine and to provide broader access and greater affordability for the patients who rely on it”.
Dec. 23, 2024 -- The FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Studies have shown that when ...
Accelerated approval was based on promising results from the ongoing Phase III BREAKWATER trial. The FDA has granted accelerated approval to Pfizer’s Braftovi (encorafenib) in combination with ...
BRAFTOVI ® (encorafenib) is indicated, in combination with cetuximab and mFOLFOX6, for the treatment of patients with metastatic colorectal cancer (mCRC) with a BRAF V600E mutation, as detected by an ...
the FDA received 1,516 requests for this designation, and only 587 have been granted. This is in line with previous years, during which around 30-40% of requests have been approved. Dostarlimab ...
Trump had demanded. Carl Hulse Maya C. Miller and Catie Edmondson The Senate approved legislation to avert a federal government shutdown just after a midnight deadline, capping a chaotic week in ...